Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Luis E. Benlloch
Observed names:
L Benlloch,
L. Benlloch,
Luis Benlloch,
Luis Benlloch Biologist
Institutions:
Hospital Universitari i Politècnic La Fe,
Instituto de Investigación Sanitaria La Fe
Observed institutions:
Hospital Universitari i Politècnic La Fe,
Grupo Español de Trasplante Hematopoyético y Terapia Celular,
S2 Grupo (Spain),
Instituto de Investigación Sanitaria La Fe
ORCID:
0009-0000-3694-7157
Observed ORCID:
0009-0000-3694-7157
OpenAlex ID:
A5017309464
Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies
2001
·
Guillermo F. Sanz
, Silvana Saavedra
, et al.
·
Blood
·
243
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry
2015
·
T Bernal
, P Martínez-Camblor
, et al.
·
Leukemia
·
122
PDF
Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors
2002
·
Javier De La Rubia
, Cristina Arbona
, et al.
·
Transfusion
·
98
Donor age‐related differences in PBPC mobilization with rHuG–CSF
2001
·
Javier De la Rubia
, Miguel A. Díaz
, et al.
·
Transfusion
·
54
Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry
1999
·
J de la Rubia
, C Martínez
, et al.
·
Bone Marrow Transplantation
·
54
FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies
2002
·
Javier de la Rubia
, Ana I. Regadera
, et al.
·
Leukemia Research
·
45
Response to erythropoietic‐stimulating agents in patients with chronic myelomonocytic leukemia
2015
·
Blanca Xicoy
, Ulrich Germing
, et al.
·
European Journal Of Haematology
·
34
Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes
2023
·
Adrian Mosquera Orgueira
, Manuel Mateo Perez Encinas
, et al.
·
HemaSphere
·
24
Second Mobilization and Collection of Peripheral Blood Progenitor Cells in Healthy Donors Is Associated with Lower CD34 + Cell Yields
2002
·
Javier De la Rubia
, Cristina Arbona
, et al.
·
Stem Cells and Development
·
17
27 Does WBC count really define two different subtypes of chronic myelomonocytic leukemia (CMML)? Analysis of a series of 119 patients
1997
·
J. Cervera
, G.F. Sanz
, et al.
·
Leukemia Research
·
13
Results of allogeneic stem cell transplantation in the Spanish MDS registry: Prognostic factors for low risk patients
2014
·
M. Díez Campelo
, M. Sánchez-Barba
, et al.
·
Leukemia Research
·
10
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification
2024
·
Adrian Mosquera Orgueira
, Manuel Mateo Perez Encinas
, et al.
·
British Journal of Haematology
·
8
An Analysis of Prognostic Markers and the Performance of Scoring Systems in 1837 Patients with Therapy-Related Myelodysplastic Syndrome - a Study of the International Working Group (IWG-PM) for Myelodysplastic Syndromes (MDS)
2015
·
Andrea Kuendgen
, Heinz Tuechler
, et al.
·
Blood
·
8
Chronic Myelomonocytic Leukemia (CMML) with More Than 15% of Ring Sideroblasts in Bone Marrow: An Overlapping Disorder Between CMML and Refractory Anemia with Ring Sideroblasts.
2009
·
Esperanza Such
, Leonor Senent
, et al.
·
Blood
·
6
Supervised Machine Learning Improves Risk Stratification in Newly Diagnosed Myelodysplastic Syndromes: An Analysis of the Spanish Group of Myelodysplastic Syndromes
2022
·
Adrian Mosquera Orgueira
, Manuel Perez Encinas
, et al.
·
Blood
·
4
A New Prognostic Scoring System Including Transfusion Dependency and Cytogenetic Abnormalities for Patients with Chronic Myelomonocytic Leukemia.
2009
·
Esperanza Such
, Jose Cervera
, et al.
·
Blood
·
4
Outcome and Prognostic Factors after Unrelated Donor Umbilical Cord Blood Transplantation in Adult Patients with Hematologic Malignancies Transplanted in Early Disease Stages.
2004
·
Guillermo Sanz
, Ignacio Lorenzo
, et al.
·
Blood
·
4
Treatment Patterns and Overall Survival in Patients with Intermediate-Risk MDS: A Retrospective Analysis in the Spanish MDS Registry
2021
·
María Diez-Campelo
, Luis E. Benlloch
, et al.
·
Blood
·
3
Frequency and Prognostic Significance of Cytogenetic Abnormalities in 1269 Patients with Therapy-Related Myelodysplastic Syndrome - a Study of the International Working Group (IWG-PM) for Myelodysplastic Syndromes (MDS)
2016
·
Andrea Kuendgen
, Heinz Tuechler
, et al.
·
Blood
·
2
211 Spanish Registry of Erythropoietic Stimulating Agents Study: the Largest Retrospective Study of Esas for the Treatment of Anemia in Lower Risk Mds Patients
2015
·
M. Diez Campelo
, J.I. Lorenzo
, et al.
·
Leukemia Research
·
2
297 Prognostic impact of severe thrombocytopenia in low risk myelodysplastic syndrome
2011
·
J.R. Gonzalez-Porras
, I. Cordoba
, et al.
·
Leukemia Research
·
2
SHP-1 (PTPN6) Gene Supression by FLT3/ITD Defines an Aggressive Subgroup of Myeloid Malignancies.
2006
·
Armando V. Mena-Duran
, Juan C. Pajuelo
, et al.
·
Blood
·
2
Autologous Stem Cell Transplantation after FLAG-IDA Chemotherapy for High-Risk Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemias Secondary to MDS (sAML) Does Not Improve Outcome: A PETHEMA Experience in 103 Patients.
2005
·
Guillermo F. Sanz
, Armando V. Mena-Duran
, et al.
·
Blood
·
2
Secondary Malignancies After Hematopoietic Stem Cell Transplantation
2026
·
Pedro Asensi Cantó
, Miguel Mansilla-Polo
, et al.
·
Transplantation and Cellular Therapy
·
1
P703: the Aipss-mds Machine Learning Model Predicts Overall Survival and Leukemic Transformation in Cmml: an Analysis of the Spanish Registry of Mds
2023
·
Adrian Mosquera-Orgueira
, Manuel Mateo Perez Encinas
, et al.
·
HemaSphere
·
1
Show more works
View as search
Works count:
44
Citation count:
768
H-index:
10
I10-index:
11
Year
Topic
Type